Advertisment CMED
Home Print this page Email this page Users Online: 240
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2013  |  Volume : 2  |  Issue : 1  |  Page : 9-13

Volumetric intensity modulated arc therapy in lung cancer: Current literature review


Department of Medical Physics, ProCure Proton Therapy Center, Oklahoma City, OK 73142, USA

Correspondence Address:
Suresh B Rana
Department of Medical Physics, ProCure Proton Therapy Center, 5901 West Memorial Road, Oklahoma City, OK 73142
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-0513.110758

Rights and Permissions

The volumetric intensity modulated arc therapy (VMAT) is a novel radiation technique that delivers a highly conformal radiation dose to the target by allowing the simultaneous variation of gantry rotation speed, dose rate and multiple-leaf collimators leaf positions. The aim of this study was to review the current literature on two VMAT systems, RapidArc and SmartArc with main focus on planning studies of lung cancer. A systematic review of available data was conducted using MEDLINE/PubMed with the keywords ''lung'' and "VMAT". The published data show that VMAT techniques have clear superiority over three-dimensional conformal radiation therapy with regard to improving dose conformity and sparing of organs at risks (OARs). The data indicates that for lung tumor VMAT and intensity modulated radiation therapy (IMRT) provide equivalent dose homogeneity, dose conformity and target volume coverage; however, contradictory results were obtained in terms of OARs sparing. The major advantages of VMAT over IMRT are the reduction in the number of monitor units and faster treatment delivery times without compromising the quality of the treatment plans. Moreover, faster delivery time is more patient-friendly and it minimizes intra-fractional patient motion allowing treatment volumes stay within their respective treatment margins. Current literature data shows that VMAT can be a good option to treat lung cancer; however, data on clinical trials are still lacking. The clinical trials are essential to confirm the safety and efficacy of VMAT techniques.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4413    
    Printed147    
    Emailed1    
    PDF Downloaded850    
    Comments [Add]    
    Cited by others 1    

Recommend this journal